This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Reuters
reuters.com
did:plc:jbvnehrrdqoulco4rf5gxg5r
Roche's multiple sclerosis drug fenebrutinib meets goal in late-stage trial reut.rs/4rA3MjE
https://reut.rs/4rA3MjE
2026-02-07T21:00:51.458Z